ARTA
MBII

A.R.T. Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

A.R.T. Advisors’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,529
Closed -$16K – 1854
2019
Q3 		$16K Sell
11,529
-7,300
-39% -$10.3K ﹤0.01% 1378
2019
Q2 		$28K Buy
+18,829
New +$29.1K ﹤0.01% 1282
2017
Q4 		– Sell
-23,171
Closed -$26K – 1768
2017
Q3 		$26K Buy
+23,171
New +$26.4K ﹤0.01% 1287
2015
Q4 		– Sell
-11,861
Closed -$25K – 1800
2015
Q3 		$25K Sell
11,861
-11,000
-48% -$21.4K ﹤0.01% 1309
2015
Q2 		$45K Buy
+22,861
New +$64.8K ﹤0.01% 1413
2014
Q4 		– Sell
-15,928
Closed -$42K – 1733
2014
Q3 		$42K Buy
+15,928
New +$106K ﹤0.01% 1249

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

A.R.T. Advisors's MBII Position: Q4 2019 in Review

A.R.T. Advisors sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2019, closing a stake of 11,529 shares — an estimated $16K sold.

A.R.T. Advisors first reported a position in MBII in Q3 2014 and held it in 6 quarters. The position peaked at $45K in Q2 2015. 49 funds tracked by Wall St. Rank hold MBII as of Q4 2019.

  • A.R.T. Advisors reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 11,529 Marrone Bio Innovations, Inc. shares in Q4 2019, an estimated $16K.
  • A.R.T. Advisors first reported a position in Marrone Bio Innovations, Inc. in Q3 2014 and held it in 6 quarters.
  • A.R.T. Advisors's Marrone Bio Innovations, Inc. position peaked at $45K in Q2 2015.
  • 49 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.